Real‐World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study

ABSTRACT Background Multiple myeloma (MM) carries a high venous thromboembolism (VTE) risk; aspirin shows limited efficacy, while factor‐Xa inhibitors show promise. Objectives Evaluate apixaban for primary thromboprophylaxis in newly diagnosed MM (NDMM). Methods Prospective single‐center study of co...

Descripció completa

Dades bibliogràfiques

Autors principals:	K. Alexandra Sanchez, Gabriela Cesarman‐Maus, Michelle Flores‐Cruz, Beatriz Cabello, Ramiro Espinoza, Omar Eduardo Fernandez‐Vargas
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-06-01
Col·lecció:	eJHaem
Matèries:	Anti‐Xa oral anticoagulants multiple myeloma thromboprophylaxis thrombotic risk scores venous thromboembolism
Accés en línia:	https://doi.org/10.1002/jha2.70325
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!